Sentieon develops and provides advanced bioinformatics solutions for genomics data analysis in the life sciences and clinical sectors. Their suite of secondary analysis tools processes genomic data with high efficiency, speed, and accuracy. The company's flagship products include Sentieon DNAseq for germline DNA analysis and Sentieon TNseq for tumor-normal somatic variant detection, offering scalable and upgradable solutions for various genomic applications.
Sentieon's technology accelerates genomic data processing through CPU/ARM optimization, providing drop-in replacements and improvements for industry-standard tools like BWA-MEM, STAR, Minimap2, GATK, and Mutect2. Their DNAscope pipeline supports both short and long-read sequencing data, enabling comprehensive genomic analysis. Sentieon's innovations contribute to advancing precision medicine by enhancing the speed and accuracy of genomic data interpretation.
